Abstract:AimsCopy number variant-sequencing (CNV-seq) and exome sequencing (ES) have been used as powerful tools in understanding the role of genetic variants in congenital heart diseases (CHDs). A few previous large cohort studies have utilized CNV-seq and ES to investigate prenatally diagnosed CHD. Here, we sought to determine the value of CNV-seq and ES for genetic evaluation of foetal CHDs. Methods and resultsWe recruited 398 pregnant women diagnosed with CHDs between 8 January 2017 and 30 November 2020. CNV-seq and ES were performed on foetal and parent samples. CHD cases were classified following the guidelines of the International Paediatric and Congenital Cardiac Code and the Tenth and Eleventh Revisions of the International Classification of Diseases. Data on aneuploids (AUP), pathogenic CNVs (pCNVs), and single nucleotide variants (SNVs) were collected and compared, following appropriate procedures. We identified genetic abnormalities in 129 (32.41%) foetuses. These abnormalities included AUP (10.80%), pCNVs (13.32%), and SNVs (8.04%). ES analysis yielded higher SNVs in cases without AUP or pCNVs. Non-isolated CHDs were associated with higher genetic abnormalities than isolated CHDs, mainly due to AUP differences between the two groups. The prevalence of genetic defects was the highest in foetuses with atrioventricular septal defects (AVSD), left ventricular outflow tract obstruction (LVOTO), and conotruncal defects (CTD). AVSD and anomalies of atrioventricular junctions and valves were associated with AUP abnormalities. CTD, anomalies of extrapericardial arterial trunks, and anomalies of the ventricular outflow tracts were the most common CHD categories diagnosed using CNVs. The most common CHDs associated with single ventricle (SV) abnormalities were heterotaxy (Hex) (14.89%), LVOTO (14.58%), and ventricular septal defect (VSD) (26.67%, 4/15). Although the ES yields were higher than CNV-seq for VSD (44.4%, 4/9), LVOTO (20%, 7/35), Hex (14.89%, 7/47), and CTD (9.1%, 11/121), its diagnostic yield did not increase for SV (6.7%, 1/15), AVSD (3.8%, 1/26), or right ventricular obstruction defects (2.6%, 1/38). The most common mutations were observed in KMT2D, CHD7, and NOTCH1. ConclusionsTo our knowledge, this is the largest cohort study to investigate the incidence of SNVs using ES in foetal CHD. CNV-seq and ES identified genetic abnormalities in nearly 1/3 of foetal CHD cases. Thus, CNV-seq and ES can provide clinically relevant information for pregnancy management.

ENU-based dominant genetic screen identifies contractile and neuronal gene mutations in congenital heart disease

NEXN Inhibits GATA4 and Leads to Atrial Septal Defects in Mice and Humans

Abstract 16596: Dominant Mouse Mutagenesis Screen Unveils a Complex Genetic Architecture for Congenital Heart Disease

Extensive Identification of Genes Involved in Congenital and Structural Heart Disorders and Cardiomyopathy

Molecular convergence of risk variants for congenital heart defects leveraging a regulatory map of the human fetal heart

Multiple gene variations contributed to congenital heart disease via GATA family transcriptional regulation

Functional dissection of human cardiac enhancers and noncoding de novo variants in congenital heart disease

Genetic Analysis of Rare Coding Mutations of CELSR1-3 in Congenital Heart and Neural Tube Defects in Chinese People.

MEF2C Loss-of-function Mutation Contributes to Congenital Heart Defects.

In Silico Analyses Reveal the Relationship Between SIX1/EYA1 Mutations and Conotruncal Heart Defects

Whole-exome sequencing of pathogenic genes in a family with congenital heart disease: A case report

An update on the molecular diagnosis of congenital heart disease: focus on loss-of-function mutations

Screening of Candidate Key Genes Associated with Congenital Heart Disease Using Bioinformatics Data Analysis

Genetic Architecture in Neonatal Intensive Care Unit Patients with Congenital Heart Defects: a Retrospective Study from the China Neonatal Genomes Project.

A genetic and developmental biological approach for a family with complex congenital heart diseases—evidence of digenic inheritance

The Expression Profile Analysis of NKX2-5 Knock-out Embryonic Mice to Explore the Pathogenesis of Congenital Heart Disease.

Identification Of Novel Single-Nucleotide Variants With Potential Of Mediating Malfunction Of Microrna In Congenital Heart Disease

A Machine Learning Classifier to Identify and Prioritise Genes Associated with Cardiac Development

Genetic aetiology distribution of 398 foetuses with congenital heart disease in the prenatal setting

Novel PITX2c Loss-of-function Mutations Associated with Complex Congenital Heart Disease.

Genetics and etiology of congenital heart disease